Glenmark receives approval for Trial of its new drug in patients with Advanced Solid Tumors and…
Glenmark Pharmaceuticals, on Monday, announced that it has received approval from the Indian drug regulator, Drug Controller General of India (DCGI), to conduct a Phase 1 clinical…
Read More...
Read More...